Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 clinical trial updates the safety and feasibility of combining gefitinib, docetaxel, and radiation therapy for patients with st…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer [Phase 3]
ARCHER 1009 is a Phase 3 trial comparing dacomitinib (PF-00299804) with erlotinib in advanced non-small cell lung cancer. The results have b…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study assessing more frequent administration of lower-dose chemotherapy with bevacizumab (Avastin) for advanced non-squamous non-s…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer [Phase 2]
This is a Phase II trial update of Cabazitaxel-XRP6258 in advanced non-small cell lung cancer (Stage IV/metastatic). Results were posted in …
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating a triplet drug combination as first-line therapy for metastatic non-squamous non-small cell lung cancer; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for CRLX101 (NLG207) in advanced non-small cell lung cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35 [Phase 2]
The ICORG 06-35 phase 2 trial evaluating PET/CT imaging to guide 3D conformal radiation therapy for non-small cell lung cancer that cannot b…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR" [Phase 2]
A randomized phase 2 study comparing atezolizumab versus docetaxel in patients with locally advanced or metastatic non-small cell lung cance…
-
CLINICAL_TRIALS withdrawal · 2017-05-23Clinical Trial Update: Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR) [Phase 2]
A Phase 2 trial (ImmunoSABR) combining SABR and L19-IL2 for stage IV non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) [Phase 2]
Phase 2 study P02143 evaluating temozolomide for brain metastases from non-small-cell lung cancer has been terminated. The sponsor is Merck …
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD) [Phase 2]
Phase 2 trial evaluating concurrent and non-concurrent chemotherapy with radiotherapy, or radiotherapy alone, using intensity-modulated radi…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating pemetrexed disodium in combination with cisplatin for patients undergoing surgery for stages I–III non-small cell l…
-
CLINICAL_TRIALS research · 2017-05-19Clinical Trial Update: Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
A completed clinical trial biomarker study analyzing blood samples from patients with non-small cell lung cancer treated with carboplatin an…
-
CLINICAL_TRIALS research · 2017-05-19Clinical Trial Update: Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer
The update describes the completion of a study that developed a predictive model for progression-free survival in patients with non-small ce…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Clinical trial update describing a correlative study using blood and tissue samples from patients with non-small cell lung cancer treated wi…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) [Phase 2]
Phase 2 study of PRO95780 in previously untreated, advanced-stage non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Biomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With Erlotinib Hydrochloride
This clinical trial update examines biomarkers that may predict response in patients with non-small cell lung cancer who were previously tre…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Bone Metastasis on the Survival of Gefitinib Effective Patients [NA]
A completed clinical trial update examining the impact of bone metastasis on survival outcomes in non-small cell lung cancer patients treate…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598
This update describes the investigation of HER-2 mutations in tumor samples from patients with advanced non-small cell lung cancer who were …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate
A completed clinical trial analyzing blood biomarkers in patients with refractory non-small cell lung cancer who were previously treated wit…
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation [Phase 2]
Phase 2 clinical trial evaluating icotinib in combination with SBRT for patients with metastatic non-squamous non-small cell lung cancer har…
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung Cancer
This clinical trial investigates how genetic polymorphisms influence the effectiveness of platinum-based chemotherapy in non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer [Phase 2]
Phase 2 study assessing dovitinib with biomarkers in advanced non-small cell lung cancer and advanced colorectal cancer has completed with p…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial of GSK1572932A as adjuvant therapy in tumor-antigen-positive non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC [Phase 2]
This Phase 2 trial evaluating cisplatin with nab-paclitaxel for Stage IIIA non-small cell lung cancer has been terminated with results poste…